ELEVATION POINT WEALTH PARTNERS, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1744349
DENVER, CO
Position in VRTX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$906,029
-$62,347 QoQ
Shares Held
2,029
-5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ELEVATION POINT WEALTH PARTNERS, LLC holds $14,646,389 across 20 Biotechnology names. VRTX ranks #3 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
367,179 | $5,309,408 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
167,807 | $2,151,285 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,029 | $906,029 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,977 | $750,957 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
895 | $691,512 | |
| 6 | ABVX |
Abivax S.A.
|
5,730 | $638,035 | |
| 7 | INSM |
INSMED Inc
|
3,674 | $600,772 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
18,884 | $523,086 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $906,029 | 2,029 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $968,376 | 2,136 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $659,913 | 1,685 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $148,251 | 333 | Shares | Sole | 2026-02-03 | |
| 2020-09-30 | $479,747 | 1,763 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $280,729 | 967 | Shares | Sole | 2020-07-09 | |
| No filing history on record for this holder in this stock. | ||||||